Acute effects of caffeine ingestion at rest in humans with impaired epinephrine responses

Journal of Applied Physiology

Volumn 80, Issue 3, 1996, Pages 999-1005

  Van Soeren, M ^a   Mohr, T ^b   Kjaer M ^b   Graham, T E ^b  

^a UNIVERSITY OF WESTERN ONTARIO   (Canada)

^b NONE

Author keywords

adenosine; blood pressure; free fatty acid; norepinephrine; tetraplegia

Indexed keywords

ADRENALIN; CAFFEINE;

ADULT; ARTICLE; BLOOD PRESSURE; CARDIOVASCULAR RESPONSE; DOSE RESPONSE; DRUG EFFECT; EXERCISE; FOOD INTAKE; HUMAN; HUMAN EXPERIMENT; LUNG VENTILATION; MALE; METABOLIC ACTIVATION; METABOLIC REGULATION; NORMAL HUMAN; PRIORITY JOURNAL; QUADRIPLEGIA;

EID: 0029997379     PISSN: 87507587     EISSN: None     Source Type: Journal    
DOI: 10.1152/jappl.1996.80.3.999     Document Type: Article

References (43)

1. Aksnes, A. K., T. Brundin, N. Hjeltnes, and J. Wahren. Glucose-induced thermogenesis in tetraplegic patients with low sympathoadrenal activity. Am. J. Physiol. 266 (Endocrinol. Metab. 29): E161-E170, 1994.
2. Bellet, S., A. Kershbaum, and E. M. Finck. Response of free fatty acids to coffee and caffeine. Metabolism 17: 702-707, 1968.
3. Bergmeyer, H. U. Methods of Enzymatic Analysis. New York: Academic, 1974, p. 1196-1201.
4. Biaggioni, I., J. Onrot, S. Hollister, and D. Robertson. Cardiovascular effects of adenosine infusion in man and their modulation by dipyridamole. Life Sci. 39: 2229-2236, 1986.
5. 2-receptor stimulation by circulating epinephrine. Am. J. Cardiol. 56: 3D-9D, 1980.
6. Burnham, R., G. Wheeler, Y. Bhambhani, M. Belanger, P. Erickson, and R. Steadward. Intentional induction of autonomie dysreflexia among quadriplegic athletes for performance enhancement: efficacy, safety and mechanism of action. In: Symposium of the Canadian Academy of Sport Medicine, edited by W. H. Meeuwisse. Banff, Canada: Univ. of Alberta Press, 1993, p. 1-7.
7. Campbell, M. E., S. P. Spielberg, and W. Kalow. A urinary metabolite ratio that reflects systemic caffeine clearance. Clin. Pharmacol. Ther. 42: 157-165, 1987.
8. 2-blockade on exercise endurance and muscle metabolism in humans. J. Appl. Physiol. 66: 548-554, 1989.
9. Conlee, R. K. Amphtetamine, caffeine, and cocaine. In: Ergogenics: Enhancement of Performance in Exercise and Sport, edited by D. R. Lamb and M. H. Williams. Indianapolis, IN: Brown and Benchmark, 1991, p. 285-330.
10. Cryer, P. E. Physiology and pathophysiology of the human sympathoadrenal neuro-endocrine system. N. Engl. J. Med. 303: 436-444, 1980.
11. Debarge, O., N. J. Christensen, J. L. Corbett, B. H. Eidelman, H. L. Frankel, and C. J. Mathais. Plasma catecholamines in tetraplegics. Paraplegia 12: 44-49, 1974.
12. Ensinck, J. W., R. W. Stoll, C. G. Gale, R. J. Santen, J. L. Touber, and R. H. Williams. Effect of aminophylline on the secretion of insulin, glucagon, luteinizing hormone and growth hormone in humans. J. Clin. Endocrinol. 31: 153-161, 1970.
13. Essig, D., D. L. Costill, and P. J. Van Handel. Effects of caffeine ingestion on utilization of muscle glycogen and lipid during leg ergometer cycling. Int. J. Sports Med. 1: 86-90, 1980.
14. 2 adenosine receptors in human erythroleukemia cells and in platelets. Mol. Pharmacol. 43: 2306-2313, 1993.
15. Freholm, B. B. Effect of adenosine, adenosine analogues and drugs inhibiting adenosine inactivation on lipolysis in rat fat cells. Acta Physiol. Scand. 102: 191-197, 1978.
16. Fredholm, B. B. On the mechanism of action of theophylline and caffeine Acta Med. Scand. 217: 149-153, 1985.
17. Graham, T. E., J. W. E. Rush, and M. H. van Soeren. Caffeine and exercise: metabolism and performance. Can. J. Appl. Physiol. 19: 111-138, 1994.
18. Graham, T. E., and L. L. Spriet. Performance and metabolic responses to a high caffeine dose during prolonged exercise. J. Appl. Physiol. 71: 2292-2298, 1991.
19. Graham, T. E., and L. L. Spriet. Impact of various doses of caffeine on catecolamines and metabolism during exercise. J. Appl. Physiol. 78: 867-874, 1995.
20. Halstead, L. S., S. Feldman, J. Claus-Walker, and V. C. Patel. Drug absorption in spinal cord injury. Arch. Phys. Med. Rehabil. 66: 298-301, 1985.
21. Izzo, J. L., A. Ghosal, T. Kwong, R. B. Freeman, and J. R. Jaenike. Age and prior caffeine use alter the cardiovascular and adrenomedullary responses to oral caffeine. Am. J. Cardiol. 52: 769-773, 1983.
22. 1 adenosine receptor binding. J. Exp. Pharmacol. Exp. Ther. 266: 1563-1572, 1993.
23. Kjæer, M., G. Perko, N. H. Secher, R. Boushel, N. Beyer, S. Pollack, A. Horn, A. Fernandes, T. Mohr, S. F. Lewis, and H. Galbo. Cardiovascular and ventilatory responses to electrically induced cycling with complete epidural anaesthesia in humans. Acta Physiol. Scand. 151: 199-207, 1994.
24. Kramer, G. L., and J. N. Wells. Effects of phosphodiesterase inhibitors on cyclic nucleotide levels and relaxation of pig coronary arteries. Mol. Pharmacol. 16: 813-822, 1979.
25. 3H]norepinephrine kinetics in tetraplegic chronic spinal cord injury patients. J. Auton. Pharmacol. 10: 221-226, 1990.
26. -] in humans. J. Appl. Physiol 74: 1149-1153, 1993.
27. MacNaughton, K. W., P. Sathasivam, A. L. Valerand, and T. E. Graham. Influence of caffeine on metabolic responses of men at rest in 28 and 5°C. J. Appl. Physiol. 68: 1889-1895, 1990.
28. Mathias, C., N. J. Christensen, J. L. Corvett, H. L. Frankel, and J. M. K. Spalding. Plasma catecholamines during paroxysmal neurogenic hypertension in quadriplegic man. Clin. Res. 39: 204-208, 1976.
29. Mosqueda-Garcia, R., C. J. Tseng, I. Biaggioni, R. M. Robertson, and D. Robertson. Effects of caffeine on baroreflex activity in humans. Clin. Pharmacol. Ther. 48: 568-574, 1990.
30. Mullane, K. M., and M. Williams. Adenosine and cardiovascular function. In: Adenosine and Adenosine Receptors, edited by M. Williams. Clifton, NJ: Humana, 1990, p. 289-333.
31. Robertson, D., J. C. Frolich, R. K. Carr, J. T. Watson, J. W. Hollifield, D. G. Shand, and J. A. Oates. Effects of caffeine on plasma renin activity, catecholamines and blood pressure. N. Engl. J. Med. 298: 181-186, 1978.
32. Robertson, D., D. Wade, R. Workman, R. L. Woosley, and J. A. Oates. Tolerance to the humoral and hemodynamic effects of caffeine in man. J. Clin. Invest. 67: 1111-1117, 1981.
33. 2-adrenergic supersensitivity in orthostatic hypotension due to spinal cord injury: a case report. Eur. J. Clin. Pharmacol. 41: 593-596, 1991.
34. 1-selective and nonselective β-blockade. Clin. Pharmacol. Ther. 34: 153-158, 1983.
35. Smits, P., G. Pieters, and T. Thien. The role of epinephrine in the circulatory effects of coffee. Clin. Pharmacol. Ther. 40: 431-437, 1986.
36. Van Soeren, M. H., P. Sathasivam, L. L. Spriet, and T. E. Graham. Caffeine metabolism and epinephrine resposes during exercise in users and nonusers. J. Appl. Physiol. 75: 805-812, 1993.
37. Vestal, R. E., C. E. Eiriksson, B. Musser, L. K. Ozaki, and J. B. Halter. Effect of intravenous aminophylline on plasma levels of catecholamines and related cardiovascular responses in man. Circulation 67: 162-171, 1983.
38. Wallin, B. G., and L. Stjernberg. Sympathetic activity in man after spinal cord injury. Brain 107: 183-198, 1984.
39. Weiker, H., M. Feraudi, H. Hagele, and R. Pluto. Electrochemical determination of catecholamines in urine and plasma separations with HPLC. Clin. Chim. Acta 141: 17-25, 1984.
40. Wier, J., T. D. Noakes, K. Myburgh, and B. Adams. A high carbohyrate diet negates the metabolic effects of caffeine during exercise. Med. Sci. Sports Exercise 19: 100-105, 1987.
41. 42K uptake in resting rat skeletal muscle. Med. Sd. Sports Exercise 26, Suppl.: S53, 1994.
42. Yamada, Y., Y. Nakazato, and A. Ohga. The mode of action of caffeine on catecholamine release from perfused adrenal glands of cat. Br. J. Pharmacol. 98: 351-356, 1989.
43. Zhang, J., and J. N. Wells. Efects of chronic caffeine administration on peripheral receptors. J. Pharmocol. Exp. Ther. 254: 270-276, 1990.